International Assets Investment Management, LLC Geron Corp Transaction History

International Assets Investment Management, LLC

$36.5 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$0.99 - $1.6 $14,850 - $24,000	-15,000 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$1.22 - $1.72 $18,300 - $25,800	15,000 New	15,000 $18,000
Q3 2021 Oct 28, 2021	SELL	$1.2 - $1.5 $18,000 - $22,500	-15,000 Closed	0 $0
Q2 2021 Jul 14, 2021	SELL	$1.25 - $1.83 $21,250 - $31,110	-17,000 Reduced 53.13%	15,000 $21,000
Q1 2021 Apr 19, 2021	BUY	$1.52 - $2.1 $25,840 - $35,700	17,000 Added 113.33%	32,000 $51,000
Q4 2020 Jan 22, 2021	BUY	$1.55 - $2.05 $7,750 - $10,250	5,000 Added 50.0%	15,000 $23.9 Million
Q3 2020 Oct 21, 2020	BUY	$1.59 - $2.19 $15,900 - $21,900	10,000 New	10,000 $17,000
Q2 2020 Jul 20, 2020	SELL	$1.05 - $2.18 $15,750 - $32,700	-15,000 Closed	0 $0
Q1 2020 Jul 20, 2020	BUY	$0.89 - $1.49 $13,350 - $22,350	15,000 New	15,000 $18,000

Others Institutions Holding GERN

# of Institutions

274

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.32B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.

Account